Bioimpedance Analyzers Market by Type (Single, Multi & Dual Frequency), Modality (Wired, Wireless), Application (Segmental Body Measurement, Whole Body Measurement), End User (Fitness Clubs, Home Users, Hospitals), & Region- Global Forecast to 2028

Abstract
The global bioimpedance analyzers market is projected to reach USD 927 million by 2028 from USD 564 million in 2023, at a CAGR of 10.4% during the forecast period. The growth of this market is majorly driven by the promotion of healthy lifestyles by the government, growing fitness and wellness centers, and an increase in the number of nutritionists and dieticians. However, However, issues related high cost of professional-grade bioimpedance analyzers restrain the growth of the bioimpedance analyzers market.

“The multi-frequency bioimpedance analyzers segment accounted for the highest market share in the bioimpedance analyzers market, by product, during the forecast period.”

Based on the product segment, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share is due to their integration with other technologies, such as wearable devices or imaging techniques for enhancing data analysis.

“Fitness clubs & wellness centers accounted for the highest CAGR during the forecast period.”

Based on end users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs & wellness centers, home users, and other end users. The fitness clubs & wellness centers segment dominated the bioimpedance analyzers market in 2022. This segment is expected to grow at the highest CAGR during the forecast period. The growing gyms and wellness centers and the rising awareness about health & fitness are the key factors driving market growth.

“The North America segment accounted for the highest market share in the bioimpedance analyzers market, by region, during the forecast period.”

Based on the region, the global bioimpedance analyzers market is categorized into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced bioimpedance analyzers and the increasing adoption of healthy lifestyles are supporting the growth of the bioimpedance analyzers market.

Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
• By Designation: C-level (28%), Director-level (33%), and Others (39%)
• By Region: North America (21%), Asia- Pacific (34%), Europe (30%), and RoW (15%)

Prominent companies include OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), seca GmbH & Co. KG (Germany), EVOLT 360 (Australia), SELVAS Healthcare (South Korea), Charder Electronic Co. Ltd. (China), Fook Tin Group Holdings Ltd. (China), Bodystat Ltd. (UK), Maltron International (UK), Microlife (Switzerland), BioTekna (Italy), Withings (France), Biodynamics Corporation (US), Akern (Italy), Xiaomi (China), Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd. (China), LUMSAIL Industrial Inc. (China), Microlife (Switzerland), Guangzhou Beautylife Electronic Technology Co., Ltd. (China), BioparHom (France), Sonka Medical Technology Co., Limited (China), NUMED s.a.r.l. (Badaro), Wunder Sa.Bi. Srl. (Italy), Shenzhen Yolanda Technology Co., Ltd (China), and Bodivis (Tongfang Health Technology) (China).

Research Coverage
This research report categorizes the bioimpedance analyzers market by product, modality, usage type, application, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the bioimpedance analyzers market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the bioimpedance analyzers market. Competitive analysis of upcoming startups in the bioimpedance analyzers market ecosystem is covered in this report.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bioimpedance analyzers market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:
•Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the bioimpedance analyzers market
•Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the bioimpedance analyzers market.
•Market Development: Comprehensive information about lucrative markets – the report analyses the bioimpedance analyzers market across varied regions.
•Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the bioimpedance analyzers market
•Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), Seca GmbH & Co. KG (Germany), among others in the bioimpedance analyzers market strategies.

Content
Table of Contents

1INTRODUCTION23
1.1STUDY OBJECTIVES23
1.2MARKET DEFINITION23
TABLE 1INCLUSIONS AND EXCLUSIONS23
1.3STUDY SCOPE24
1.3.1MARKETS COVERED24
1.3.2REGIONS COVERED24
1.3.3YEARS CONSIDERED25
1.4CURRENCY25
1.5STAKEHOLDERS25
1.6SUMMARY OF CHANGES26
1.7LIMITATIONS26
2RESEARCH METHODOLOGY27
2.1RESEARCH DATA27
FIGURE 1BIOIMPEDANCE ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY27
2.1.1SECONDARY DATA28
2.1.1.1Secondary sources29
2.1.2PRIMARY DATA30
FIGURE 2PRIMARY SOURCES30
TABLE 2KEY DATA FROM PRIMARY SOURCES31
2.1.2.1Key industry insights32
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS32
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION33
2.2MARKET SIZE ESTIMATION33
2.2.1BOTTOM-UP APPROACH34
FIGURE 5BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH34
2.2.1.1Growth forecast35
FIGURE 6CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS35
FIGURE 7MARKET SIZE ESTIMATION: TOP-DOWN APPROACH36
2.3MARKET BREAKDOWN AND DATA TRIANGULATION37
FIGURE 8DATA TRIANGULATION METHODOLOGY37
2.4MARKET SHARE ANALYSIS37
2.5STUDY ASSUMPTIONS38
2.6RISK ASSESSMENT38
2.7RECESSION IMPACT ANALYSIS38
 
3EXECUTIVE SUMMARY39
FIGURE 9BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION)39
FIGURE 10BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2023 VS. 2028 (USD BILLION)40
FIGURE 11BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2023 VS. 2028 (USD BILLION)40
FIGURE 12BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD BILLION)41
FIGURE 13BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2023 VS. 2028 (USD BILLION)42
FIGURE 14BIOIMPEDANCE ANALYZERS MARKET: GEOGRAPHICAL SNAPSHOT43
4PREMIUM INSIGHTS44
4.1BIOIMPEDANCE ANALYZERS MARKET OVERVIEW44
FIGURE 15INCREASED PREVALENCE OF OBESITY TO DRIVE BIOIMPEDANCE ANALYZERS MARKET44
4.2ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT AND COUNTRY (2022)45
FIGURE 16MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS ACCOUNTED FOR LARGEST SHARE IN 202245
4.3REGIONAL GROWTH OPPORTUNITIES IN BIOIMPEDANCE ANALYZERS MARKET46
FIGURE 17CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD46
4.4BIOIMPEDANCE ANALYZERS MARKET: REGIONAL MIX47
FIGURE 18ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD47
4.5BIOIMPEDANCE ANALYZERS MARKET: DEVELOPED VS. EMERGING ECONOMIES47
FIGURE 19EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD47
5MARKET OVERVIEW48
5.1INTRODUCTION48
5.2MARKET DYNAMICS48
FIGURE 20BIOIMPEDANCE ANALYZERS MARKET DYNAMICS48
5.2.1DRIVERS49
5.2.1.1Increasing prevalence of lifestyle diseases49
5.2.1.2Initiatives by governments and private organizations to promote healthy lifestyles49
5.2.1.3Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers50
5.2.2RESTRAINTS50
5.2.2.1Presence of alternative methods50
5.2.2.2High cost of analyzers51
TABLE 3BIOIMPEDANCE ANALYZERS: AVERAGE PRICE RANGE, BY COMPANY51
5.2.3OPPORTUNITIES51
5.2.3.1Emerging markets across Asia Pacific and Latin America51
5.2.3.2Integration with wearable devices52
5.2.4CHALLENGES52
5.2.4.1Inconsistency in accuracy of different bioimpedance analyzers52
5.3SUPPLY CHAIN ANALYSIS53
FIGURE 21DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES54
5.4VALUE CHAIN ANALYSIS54
FIGURE 22BIOIMPEDANCE ANALYZERS MARKET: VALUE CHAIN ANALYSIS54
5.5ECOSYSTEM ANALYSIS55
FIGURE 23BIOIMPEDANCE ANALYZERS MARKET: ECOSYSTEM ANALYSIS55
5.5.1ROLE IN ECOSYSTEM56
FIGURE 24BIOIMPEDANCE ANALYZERS MARKET ECOSYSTEM: KEY PLAYERS56
5.6REGULATORY LANDSCAPE57
5.6.1NORTH AMERICA57
5.6.1.1US57
TABLE 4US FDA: MEDICAL DEVICE CLASSIFICATION57
5.6.1.2Canada58
TABLE 5CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS58
5.6.2EUROPE58
5.6.3ASIA PACIFIC59
5.6.3.1Japan59
TABLE 6JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA59
5.6.3.2China60
TABLE 7CHINA: CLASSIFICATION OF MEDICAL DEVICES60
5.6.3.3India60
TABLE 8REGULATORY AUTHORITIES61
5.7PORTER’S FIVE FORCES ANALYSIS62
5.7.1THREAT OF NEW ENTRANTS62
5.7.2BARGAINING POWER OF SUPPLIERS62
5.7.3BARGAINING POWER OF BUYERS62
5.7.4INTENSITY OF COMPETITIVE RIVALRY62
5.7.5THREAT OF SUBSTITUTES62
5.8PATENT ANALYSIS63
FIGURE 25PATENT ANALYSIS FOR BIOIMPEDANCE ANALYZERS (JANUARY 2013–NOVEMBER 2022)63
5.9TRADE ANALYSIS64
TABLE 9IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)64
TABLE 10EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)64
5.10TECHNOLOGY ANALYSIS65
5.11PRICING ANALYSIS66
TABLE 11AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT66
5.12TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES67
5.12.1REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS67
FIGURE 26REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS67
6BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT68
6.1INTRODUCTION69
TABLE 12BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)69
6.2MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS69
6.2.1ACCURACY AND PRECISION TO DRIVE MARKET69
TABLE 13MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY70
TABLE 14MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)70
6.3SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS71
6.3.1LOWER COST AND ACCESSIBILITY TO DRIVE MARKET71
TABLE 15SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY71
TABLE 16SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)71
6.4DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS72
6.4.1SUITABILITY FOR ADVANCED CLINICAL AND RESEARCH APPLICATIONS TO FAVOR GROWTH72
TABLE 17DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY72
TABLE 18DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)72
7BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY73
7.1INTRODUCTION74
TABLE 19BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)74
7.2WIRELESS BIOIMPEDANCE ANALYZERS74
7.2.1WIRELESS BIOIMPEDANCE ANALYZERS TO HOLD LARGEST MARKET SHARE74
TABLE 20WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)75
7.3WIRED BIOIMPEDANCE ANALYZERS75
7.3.1BENEFITS OF WIRED DEVICES TO DRIVE DEMAND75
TABLE 21WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)75
8BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE76
8.1INTRODUCTION77
TABLE 22BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)77
8.2PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS77
8.2.1GROWING NUMBER OF FITNESS & WELLNESS CENTERS TO DRIVE MARKET77
TABLE 23PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)78
8.3CONSUMER-GRADE BIOIMPEDANCE ANALYZERS78
8.3.1GROWING AWARENESS OF FITNESS AND TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE MARKET78
TABLE 24CONSUMER-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)79
9BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION80
9.1INTRODUCTION81
TABLE 25BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)81
9.2SEGMENTAL BODY MEASUREMENT81
9.2.1RISING EMPHASIS ON MONITORING TRAINING EFFECTIVENESS TO BOOST ADOPTION81
TABLE 26BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION)82
9.3WHOLE-BODY MEASUREMENT82
9.3.1GROWING USE OF WHOLE-BODY ANALYZERS TO DRIVE MARKET82
TABLE 27BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION)82
10BIOIMPEDANCE ANALYZERS MARKET, BY END USER83
10.1INTRODUCTION84
TABLE 28BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)84
10.2FITNESS CLUBS & WELLNESS CENTERS84
10.2.1FITNESS CLUBS & WELLNESS CENTERS TO DOMINATE END-USER MARKET84
FIGURE 27US: NUMBER OF HEALTH CLUBS, 2012–202285
TABLE 29BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS & WELLNESS CENTERS, 2021–2028 (USD MILLION)85
10.3HOME USERS86
10.3.1AFFORDABILITY AND CONVENIENCE TO DRIVE ANALYZER ADOPTION86
TABLE 30BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2021–2028 (USD MILLION)86
10.4HOSPITALS & CLINICS87
10.4.1NEED TO MONITOR NUTRITIONAL, HYDRATION STATES AND OTHER PARAMETERS TO BOOST ADOPTION87
TABLE 31BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION)87
10.5OTHER END USERS88
TABLE 32BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)88
11BIOIMPEDANCE ANALYZERS MARKET, BY REGION89
11.1INTRODUCTION90
TABLE 33BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)90
11.2NORTH AMERICA91
FIGURE 28NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT91
TABLE 34NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)92
TABLE 35NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)92
TABLE 36NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)92
TABLE 37NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)93
TABLE 38NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)93
TABLE 39NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)93
11.2.1RECESSION IMPACT94
11.2.2US94
11.2.2.1Rising obesity rate and interest in health clubs & fitness centers to drive market94
TABLE 40US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)95
TABLE 41US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)95
TABLE 42US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)95
TABLE 43US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)96
11.2.3CANADA96
11.2.3.1High prevalence of obesity in Canada to support market growth96
TABLE 44CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)97
TABLE 45CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)97
TABLE 46CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)97
TABLE 47CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)98
11.3EUROPE98
TABLE 48EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)98
TABLE 49EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)99
TABLE 50EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)99
TABLE 51EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)99
TABLE 52EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)100
TABLE 53EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)100
11.3.1RECESSION IMPACT100
11.3.2GERMANY100
11.3.2.1Germany to hold largest market share in Europe100
TABLE 54GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)101
TABLE 55GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)101
TABLE 56GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)102
TABLE 57GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)102
11.3.3UK102
11.3.3.1Rising incidence of kidney disorders to drive market102
TABLE 58UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)103
TABLE 59UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)103
TABLE 60UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)104
TABLE 61UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)104
11.3.4FRANCE104
11.3.4.1Increasing obese population and rising prevalence of metabolic disorders to drive market104
TABLE 62FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)105
TABLE 63FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)105
TABLE 64FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)105
TABLE 65FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)106
11.3.5REST OF EUROPE106
TABLE 66REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)107
TABLE 67REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)107
TABLE 68REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)107
TABLE 69REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)108
 
11.4ASIA PACIFIC108
11.4.1RECESSION IMPACT108
FIGURE 29ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT109
TABLE 70ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)110
TABLE 71ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)110
TABLE 72ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)111
TABLE 73ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)111
TABLE 74ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)111
TABLE 75ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)112
11.4.2JAPAN112
11.4.2.1Government initiatives to drive market112
TABLE 76JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)113
TABLE 77JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)113
TABLE 78JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)113
TABLE 79JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)114
11.4.3CHINA114
11.4.3.1China to register highest CAGR in APAC market114
TABLE 80CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)115
TABLE 81CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)115
TABLE 82CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)115
TABLE 83CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)116
11.4.4AUSTRALIA116
11.4.4.1High prevalence of obesity to drive market116
TABLE 84AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)117
TABLE 85AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)117
TABLE 86AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)117
TABLE 87AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)118
11.4.5PHILIPPINES118
11.4.5.1Favorable government initiatives to support market growth118
TABLE 88PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)118
TABLE 89PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)119
TABLE 90PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)119
TABLE 91PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)119
11.4.6TAIWAN120
11.4.6.1Increasing incidence of lifestyle diseases to drive market120
TABLE 92TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)120
TABLE 93TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)120
TABLE 94TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)121
TABLE 95TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)121
11.4.7REST OF ASIA PACIFIC121
TABLE 96REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)122
TABLE 97REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)122
TABLE 98REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)122
TABLE 99REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)123
11.5REST OF THE WORLD123
11.5.1RECESSION IMPACT123
TABLE 100REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)124
TABLE 101REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)124
TABLE 102REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)124
TABLE 103REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)125
12COMPETITIVE LANDSCAPE126
12.1OVERVIEW126
12.2KEY PLAYER STRATEGIES/RIGHT TO WIN126
TABLE 104OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES126
12.3MARKET SHARE ANALYSIS127
TABLE 105BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION127
12.4COMPANY EVALUATION MATRIX (2022)128
12.4.1STARS128
12.4.2EMERGING LEADERS128
12.4.3PERVASIVE PLAYERS128
12.4.4PARTICIPANTS128
FIGURE 30BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX, 2022129
12.5COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)130
12.5.1PROGRESSIVE COMPANIES130
12.5.2STARTING BLOCKS130
12.5.3RESPONSIVE COMPANIES130
12.5.4DYNAMIC COMPANIES130
FIGURE 31BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022131
12.6COMPETITIVE BENCHMARKING132
TABLE 106BIOIMPEDANCE ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS132
TABLE 107PRODUCT FOOTPRINT ANALYSIS133
TABLE 108REGIONAL FOOTPRINT ANALYSIS134
TABLE 109BIOIMPEDANCE ANALYZERS MARKET: DETAILED LIST OF KEY START-UPS/SMES135
12.7COMPETITIVE SCENARIO135
12.7.1PRODUCT LAUNCHES135
TABLE 110PRODUCT LAUNCHES, 2020–2023135
12.7.2DEALS136
TABLE 111DEALS, 2020–2023136
12.7.3OTHER DEVELOPMENTS136
TABLE 112OTHER DEVELOPMENTS, 2020–2023136
13COMPANY PROFILES137
13.1KEY PLAYERS137
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1OMRON CORPORATION137
TABLE 113OMRON CORPORATION: BUSINESS OVERVIEW137
FIGURE 32OMRON CORPORATION: COMPANY SNAPSHOT (2022)138
13.1.2TANITA CORPORATION140
TABLE 114TANITA CORPORATION: BUSINESS OVERVIEW140
13.1.3INBODY CO., LTD.143
TABLE 115INBODY CO., LTD.: BUSINESS OVERVIEW143
TABLE 116INBODY CO., LTD.: DEALS144
TABLE 117INBODY CO., LTD.: OTHER DEVELOPMENTS144
13.1.4RJL SYSTEMS, INC.145
TABLE 118RJL SYSTEMS, INC.: BUSINESS OVERVIEW145
13.1.5SECA GMBH & CO. KG147
TABLE 119SECA GMBH & CO. KG: BUSINESS OVERVIEW147
13.1.6EVOLT 360149
TABLE 120EVOLT 360: BUSINESS OVERVIEW149
13.1.7SELVAS HEALTHCARE (FORMERLY JAWON MEDICAL)150
TABLE 121SELVAS HEALTHCARE: BUSINESS OVERVIEW150
13.1.8FOOK TIN TECHNOLOGIES LTD.151
TABLE 122FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW151
13.1.9BODYSTAT LTD.152
TABLE 123BODYSTAT LTD.: BUSINESS OVERVIEW152
TABLE 124BODYSTAT LTD.: PRODUCT LAUNCHES152
13.1.10CHARDER ELECTRONIC CO., LTD.153
TABLE 125CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW153
13.1.11MALTRON INTERNATIONAL154
TABLE 126MALTRON INTERNATIONAL: BUSINESS OVERVIEW154
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2OTHER PLAYERS155
13.2.1BIOTEKNA155
13.2.2BIODYNAMICS CORPORATION155
13.2.3AKERN156
13.2.4WITHINGS156
13.2.5XIAOMI157
13.2.6SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.157
13.2.7LUMSAIL INDUSTRIAL INC.158
13.2.8GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.158
13.2.9BIOPARHOM159
13.2.10MICROLIFE159
13.2.11SONKA MEDICAL TECHNOLOGY CO., LIMITED160
13.2.12NUMED S.A.R.L.160
13.2.13WUNDER SA.BI. SRL.161
13.2.14SHENZHEN YOLANDA TECHNOLOGY CO., LTD161
13.2.15BODIVIS (TONGFANG HEALTH TECHNOLOGY CO., LTD.)162
14APPENDIX163
14.1DISCUSSION GUIDE163
14.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL167
14.3CUSTOMIZATION OPTIONS169
14.4RELATED REPORTS169
14.5AUTHOR DETAILS170